Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC)
Journal of UOEH · 01.06.2018 · 40 (2) · 173-189
DOI: 10.7888/juoeh.40.173 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of UOEH, erschienen am 01.06.2018. Verfasst von Kazue Yoneda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Surgery (Chest Surgery), School of Medicine, University of Occupational and Environmental Health, Japan. Hauptthemen laut MEDLINE: Immunotherapy. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Surgery (Chest Surgery), School of Medicine, University of Occupational and Environmental Health, Japan.
Zitieren
APA
Yoneda, K., Imanishi, N., Ichiki, Y., & Tanaka, F. (2018). Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC). Journal of UOEH, 40(2), 173-189. https://doi.org/10.7888/juoeh.40.173
Vancouver
Yoneda K, Imanishi N, Ichiki Y, Tanaka F. Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC). Journal of UOEH. 2018;40(2):173-189. doi:10.7888/juoeh.40.173
BibTeX
@article{Yoneda2018,
author = {Yoneda, Kazue and Imanishi, Naoko and Ichiki, Yoshinobu and Tanaka, Fumihiro},
title = {Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC)},
journal = {Journal of UOEH},
year = {2018},
volume = {40},
number = {2},
pages = {173--189},
doi = {10.7888/juoeh.40.173}
}
EUVIMED